<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34932446</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong.</ArticleTitle><Pagination><StartPage>62</StartPage><EndPage>68</EndPage><MedlinePgn>62-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2801.211099</ELocationID><Abstract><AbstractText>To determine the effects of nonpharmaceutical interventions (NPIs) for coronavirus disease on pediatric hospitalizations for infection with respiratory viruses other than severe acute respiratory syndrome coronavirus 2, we analyzed hospital data for 2017-2021. Compared with 2017-2019, age-specific hospitalization rates associated with respiratory viruses greatly decreased in 2020, when NPIs were in place. Also when NPIs were in place, rates of hospitalization decreased among children of all ages for infection with influenza A and B viruses, respiratory syncytial virus, adenovirus, parainfluenza viruses, human metapneumovirus, and rhinovirus/enterovirus. Regression models adjusted for age and seasonality indicated that hospitalization rates for acute febrile illness/respiratory symptoms of any cause were reduced by 76% and by 85%-99% for hospitalization for infection with these viruses. NPIs in Hong Kong were clearly associated with reduced pediatric hospitalizations for respiratory viruses; implementing NPIs and reopening schools were associated with only a small increase in hospitalizations for rhinovirus/enterovirus infections.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Susan S</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Cowling</LastName><ForeName>Benjamin J</ForeName><Initials>BJ</Initials></Author><Author ValidYN="Y"><LastName>Peiris</LastName><ForeName>J S Malik</ForeName><Initials>JSM</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Eunice L Y</ForeName><Initials>ELY</Initials></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wilfred H S</ForeName><Initials>WHS</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kwok Piu</ForeName><Initials>KP</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006723" MajorTopicYN="N" Type="Geographic">Hong Kong</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2019 novel coronavirus disease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hong Kong</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">coronavirus disease</Keyword><Keyword MajorTopicYN="N">nonpharmaceutical interventions</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">pediatrics</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">respiratory virus hospitalization</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword><Keyword MajorTopicYN="N">viruses</Keyword><Keyword MajorTopicYN="N">zoonoses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>21</Day><Hour>17</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34932446</ArticleId><ArticleId IdType="pmc">PMC8714236</ArticleId><ArticleId IdType="doi">10.3201/eid2801.211099</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5:e279–88. 10.1016/S2468-2667(20)30090-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(20)30090-6</ArticleId><ArticleId IdType="pmc">PMC7164922</ArticleId><ArticleId IdType="pubmed">32311320</ArticleId></ArticleIdList></Reference><Reference><Citation>The Government of the Hong Kong Special Administrative Region. Thematic Household Survey Report No. 68 [cited 2021 Apr 5]. https://www.censtatd.gov.hk/hkstat/sub/sp140.jsp?productCode=B1130201</Citation></Reference><Reference><Citation>Chiu SS, Chan K-H, Chen H, Young BW, Lim W, Wong WHS, et al. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong. Clin Infect Dis. 2009;49:1016–21. 10.1086/605570</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/605570</ArticleId><ArticleId IdType="pubmed">19722912</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SS, Chan KH, Chen H, Young BW, Lim W, Wong WH, et al. Virologically confirmed population-based burden of hospitalization caused by respiratory syncytial virus, adenovirus, and parainfluenza viruses in children in Hong Kong. Pediatr Infect Dis J. 2010;29:1088–92. 10.1097/INF.0b013e3181e9de24</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e3181e9de24</ArticleId><ArticleId IdType="pubmed">20622713</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SS, Chan KH, So LY, Chen R, Chan EL, Peiris JSM. The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong. Vaccine. 2012;30:1895–900. 10.1016/j.vaccine.2011.12.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.12.027</ArticleId><ArticleId IdType="pubmed">22222872</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SS, Ho P-L, Khong P-L, Ooi C, So LY, Wong WHS, et al. Population-based incidence of community-acquired pneumonia hospitalization in Hong Kong children younger than 5 years before universal conjugate pneumococcal immunization. J Microbiol Immunol Infect. 2016;49:225–9. 10.1016/j.jmii.2014.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2014.05.007</ArticleId><ArticleId IdType="pubmed">25070281</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowling BJ, Wu P, Lo JYC, Chan K-H, Chan ELY, Fang VJ, et al. Population-based pediatric hospitalization burden of lineage-specific influenza B in Hong Kong, 2004–2014. Clin Infect Dis. 2017;65:300–7. 10.1093/cid/cix312</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix312</ArticleId><ArticleId IdType="pmc">PMC5848250</ArticleId><ArticleId IdType="pubmed">28387792</ArticleId></ArticleIdList></Reference><Reference><Citation>Angoulvant F, Ouldali N, Yang DD, Filser M, Gajdos V, Rybak A, et al. Coronavirus disease 2019 pandemic: impact caused by school closure and national lockdown on pediatric visits and admissions for viral and nonviral infections—a time series analysis. Clin Infect Dis. 2021;72:319–22. 10.1093/cid/ciaa710</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa710</ArticleId><ArticleId IdType="pmc">PMC7314162</ArticleId><ArticleId IdType="pubmed">33501967</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Brusselen D, De Troeyer K, Ter Haar E, Vander Auwera A, Poschet K, Van Nuijs S, et al. Bronchiolitis in COVID-19 times: a nearly absent disease? Eur J Pediatr. 2021;180:1969–73. 10.1007/s00431-021-03968-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-03968-6</ArticleId><ArticleId IdType="pmc">PMC7847293</ArticleId><ArticleId IdType="pubmed">33517482</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh DK, Foley DA, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The impact of coronavirus disease public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter. Clin Infect Dis. 2021;72:2199–202. 10.1093/cid/ciaa1475</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1475</ArticleId><ArticleId IdType="pmc">PMC7543326</ArticleId><ArticleId IdType="pubmed">32986804</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1305–9. 10.15585/mmwr.mm6937a6</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6937a6</ArticleId><ArticleId IdType="pmc">PMC7498167</ArticleId><ArticleId IdType="pubmed">32941415</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al.; NPIsImpactOnFlu Consortium. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12:1001. 10.1038/s41467-021-21157-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21157-9</ArticleId><ArticleId IdType="pmc">PMC7881137</ArticleId><ArticleId IdType="pubmed">33579926</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddadin Z, Schuster JE, Spieker AJ, Rahman H, Blozinski A, Stewart L, et al. Acute respiratory illnesses in children in the SARS-CoV-2 pandemic: prospective multicenter study. Pediatrics. 2021;148:e2021051462. 10.1542/peds.2021-051462</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2021-051462</ArticleId><ArticleId IdType="pmc">PMC8338906</ArticleId><ArticleId IdType="pubmed">33986150</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong MW, Leung NHL, Cowling BJ, Wu P. Upper respiratory infections in schools and childcare centers reopening after COVID-19 dismissals, Hong Kong. Emerg Infect Dis. 2021;27:1525–7. 10.3201/eid2705.210277</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2705.210277</ArticleId><ArticleId IdType="pmc">PMC8084506</ArticleId><ArticleId IdType="pubmed">33596168</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong MW, Cowling BJ, Leung GM, Wu P. Letter to the editor: COVID-19 cases among school-aged children and school-based measures in Hong Kong, July 2020. Euro Surveill. 2020;25:pii=2001671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502885</ArticleId><ArticleId IdType="pubmed">32945255</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL, Chu DKW, Shiu EYC, Chan K-H, McDevitt JJ, Hau BJP, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26:676–80. 10.1038/s41591-020-0843-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0843-2</ArticleId><ArticleId IdType="pmc">PMC8238571</ArticleId><ArticleId IdType="pubmed">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson NM, Laydon D, Nedjati-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. [cited 2021 Oct 13]. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-9-impact-of-npis-on-covid-19.</Citation></Reference><Reference><Citation>United Nations Educational, Scientific and Cultural Organization. Education: from disruption to recovery [cited 2021 Oct 13]. https://en.unesco.org/covid19/educationresponse</Citation></Reference><Reference><Citation>United Nations Educational, Scientific and Cultural Organization. Adverse consequences of school closures [cited 2021 Apr 12]. https://en.unesco.org/covid19/educationresponse/consequences</Citation></Reference><Reference><Citation>Donohue JM, Miller E. COVID-19 and school closures. JAMA. 2020;324:845–7. 10.1001/jama.2020.13092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.13092</ArticleId><ArticleId IdType="pubmed">32745182</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng VC-C, Wong S-C, Chuang VW-M, So SY-C, Chen JH-K, Sridhar S, et al. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2. J Infect. 2020;81:107–14. 10.1016/j.jinf.2020.04.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7177146</ArticleId><ArticleId IdType="pubmed">32335167</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>